Subcutaneous immunoglobulin as first‐line therapy in treatment‐naive patients with chronic inflammatory demyelinating polyneuropathy: randomized controlled trial study

Abstract

In treatment-naive patients with CIDP, short-lasting SCIG and IVIG therapy improve motor performance to a similar degree, but with earlier maximal improvement following IVIG than SCIG treatment.